Jessica L. Mega, MD, MPH

Jessica L. Mega, MD, MPH, is the Co-Founder and Chief Medical and Scientific Officer at Verily. As CMSO, Dr. Mega's focus is on translating technological innovations and scientific insights into partnerships and programs that improve patient outcomes and healthcare. She oversees all of Verily's clinical and science efforts.

As a faculty member at Harvard Medical School, a senior investigator with the TIMI Study Group, and a cardiologist at Brigham and Women’s Hospital, she led large, international, randomized trials evaluating novel cardiovascular therapies. She also directed the TIMI Study Group’s Genetics Program. Her findings have been published in the New England Journal of Medicine, Lancet, JAMA, and elsewhere. She has served on the Advisory Group for the California Governor’s Precision Medicine work. Dr. Mega currently sits on the Advisory Board for the Duke-Margolis Center for Health Policy and the Board of Directors for Danaher Corporation.

Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC).